Guangdong Xinyaguang Cable
001382
Haimo Technologies Group Corp.
300084
Shaoyang Victor Hydraulics
301079
KLT
831689
Qingdao Tianneng Heavy Industries
300569
CN Stock MarketDetailed Quotes
002603 Shijiazhuang Yiling Pharmaceutical
- 14.70
- +0.10+0.68%
Market Closed Mar 21 15:00 CST
24.56BMarket Cap165.17P/E (TTM)
14.98High14.59Low342.83KlotVolume14.92Open14.60Pre Close505.09MTurnover2.49%Turnover Ratio18.17P/E (Static)1.67BShares20.6152wk High2.13P/B20.23BFloat Cap13.2552wk Low16.06Limit Up1.38BShs Float53.16Historical High13.14Limit Down2.67%Amplitude4.79Historical Low0.30Dividend TTM14.73Avg Price162.56KlotAsk2.04%Div YieldTTM100Lot Size150.36KlotBid
Shijiazhuang Yiling Pharmaceutical News
Eling Pharmaceutical: Announcement on Supplementary Pledges for Some Shares of Actual Controllers
Eling Pharmaceutical: Notice on obtaining a drug registration certificate for the innovative traditional Chinese medicine, Astragalus nasal medicine tablets
Eling Pharmaceutical: 2024 Annual Results Forecast
Eling Pharmaceutical: Notice on Withdrawal of Clinical Trial Application for G201-Na Capsule Drugs
Eling Pharmaceutical: Announcement on the extension of the actual controller\'s partial share pledge
Eling Pharmaceutical: Notice on approval of the registration application for clinical trials of the new Chinese medicine Lianhua Yuping granular drug
Eling Pharmaceutical: Notice on Wholly Owned Subsidiary Formulation Products Obtaining U.S. FDA Approval Numbers
Eling Pharmaceutical: Announcement on the inclusion of the company\'s drugs in the “National Medical Insurance Catalogue” through negotiations
Eling Pharmaceutical: Record of Investor Relations Activities for October 29, 2024
Eling Pharmaceutical: Report for the third quarter of 2024
Eling Pharmaceutical: Notice on Acceptance of Clinical Trial Applications for Innovative Chemical Drug G201-Na Capsules
Eling Pharmaceutical: Record of Investor Relations Activities on October 15, 2024
Eling Pharmaceutical: Announcement on attending the 2024 Online Group Reception Day for Investors of Listed Companies in Hebei and the 2024 Semi-Annual Report Results Briefing
Eling Pharmaceutical: Announcement on the acceptance of the application for clinical trials of the new traditional Chinese medicine Lianhua Yuping granular drug
Eling Pharmaceutical: Announcement on Release of the Pledge of Part of the Actual Controller\'s Shares
Eling Pharmaceutical: Announcement on the actual controller\'s partial share pledge
Eling Pharmaceutical: Investor Relations Activity Record Form for August 28, 2024
Eling Pharmaceutical: Semi-Annual Report 2024
Eling Pharmaceutical: Announcement of Resolutions of the Supervisory Board in the Semi-Annual Report
Eling Pharmaceutical: Announcement of Board Resolutions of the Semi-Annual Report
